Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 299

1.

Hyperbaric Oxygen Therapy Does Not Reduce Indications for Amputation in Patients With Diabetes With Nonhealing Ulcers of the Lower Limb: A Prospective, Double-Blind, Randomized Controlled Clinical Trial.

Fedorko L, Bowen JM, Jones W, Oreopoulos G, Goeree R, Hopkins RB, O'Reilly DJ.

Diabetes Care. 2016 Jan 6. pii: dc152001. [Epub ahead of print]

PMID:
26740639
2.

Chemotherapy-induced gut toxicity and pain: involvement of TLRs.

Gibson RJ, Coller JK, Wardill HR, Hutchinson MR, Smid S, Bowen JM.

Support Care Cancer. 2015 Nov 19. [Epub ahead of print]

PMID:
26581898
3.

Propensity Score Matching Does not Always Remove Confounding within an Economic Evaluation Based on a Non-Randomized Study.

Guertin JR, Bowen JM, O'Reilly D, Tarride J.

Value Health. 2015 Nov;18(7):A338. doi: 10.1016/j.jval.2015.09.131. Epub 2015 Oct 20. No abstract available.

PMID:
26531915
4.

Tight junction defects are seen in the buccal mucosa of patients receiving standard dose chemotherapy for cancer.

Wardill HR, Logan RM, Bowen JM, Van Sebille YZ, Gibson RJ.

Support Care Cancer. 2015 Oct 6. [Epub ahead of print]

PMID:
26441079
5.

Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey.

Bowen JM, Campbell K, Sutherland S, Bartlett A, Brooks D, Qureshi R, Goldstein R, Gershon AS, Prevost S, Samis L, Kaplan AG, Hopkins RB, MacDougald C, Nunes E, O'Reilly DJ, Goeree R.

Ont Health Technol Assess Ser. 2015 Mar 1;15(8):1-67. eCollection 2015.

6.

What are the predictive factors in the risk and severity of chemotherapy-induced gastrointestinal toxicity?

Gibson RJ, Bowen JM, Coller JK.

Future Oncol. 2015;11(17):2367-70. doi: 10.2217/FON.15.138. Epub 2015 Aug 13. No abstract available.

7.

ErbB small molecule tyrosine kinase inhibitor (TKI) induced diarrhoea: Chloride secretion as a mechanistic hypothesis.

Van Sebille YZ, Gibson RJ, Wardill HR, Bowen JM.

Cancer Treat Rev. 2015 Jul;41(7):646-52. doi: 10.1016/j.ctrv.2015.05.011. Epub 2015 Jun 6. Review.

PMID:
26073491
8.

Extramedullary hematopoiesis in a sentinel lymph node as an early sign of chronic myelomonocytic leukemia.

Bowen JM, Perry AM, Quist E, Akhtari M.

Case Rep Pathol. 2015;2015:594970. doi: 10.1155/2015/594970. Epub 2015 Apr 16.

9.

Circulating Serum Exosomal miRNAs As Potential Biomarkers for Esophageal Adenocarcinoma.

Chiam K, Wang T, Watson DI, Mayne GC, Irvine TS, Bright T, Smith L, White IA, Bowen JM, Keefe D, Thompson SK, Jones ME, Hussey DJ.

J Gastrointest Surg. 2015 Jul;19(7):1208-15. doi: 10.1007/s11605-015-2829-9. Epub 2015 May 6.

PMID:
25943911
10.

Editorial Comment: Does gut-derived inflammation enhance pain signaling following chemotherapy in a Toll-like receptor 4-dependent manner?

Wardill HR, Van Sebille YZ, Bowen JM, Gibson RJ.

Curr Opin Support Palliat Care. 2015 Jun;9(2):155-6. doi: 10.1097/SPC.0000000000000139. No abstract available.

PMID:
25872125
11.

Pre-therapy mRNA expression of TNF is associated with regimen-related gastrointestinal toxicity in patients with esophageal cancer: a pilot study.

Bowen JM, White I, Smith L, Tsykin A, Kristaly K, Thompson SK, Karapetis CS, Tan H, Game PA, Irvine T, Hussey DJ, Watson DI, Keefe DM.

Support Care Cancer. 2015 Nov;23(11):3165-72. doi: 10.1007/s00520-015-2696-7. Epub 2015 Mar 27.

PMID:
25814442
12.

Evidence-based decision-making 3: Health technology assessment.

O'Reilly D, Campbell K, Vanstone M, Bowen JM, Schwartz L, Assasi N, Goeree R.

Methods Mol Biol. 2015;1281:417-41. doi: 10.1007/978-1-4939-2428-8_25.

PMID:
25694325
13.

Toll-like receptor 4 signaling: a common biological mechanism of regimen-related toxicities: an emerging hypothesis for neuropathy and gastrointestinal toxicity.

Wardill HR, Van Sebille YZ, Mander KA, Gibson RJ, Logan RM, Bowen JM, Sonis ST.

Cancer Treat Rev. 2015 Feb;41(2):122-8. doi: 10.1016/j.ctrv.2014.11.005. Epub 2014 Dec 5. Review.

PMID:
25512119
14.

Of Marfan's syndrome, mice, and medications.

Bowen JM, Connolly HM.

N Engl J Med. 2014 Nov 27;371(22):2127-8. doi: 10.1056/NEJMe1412950. Epub 2014 Nov 18. No abstract available.

PMID:
25405389
15.

Predictive model for risk of severe gastrointestinal toxicity following chemotherapy using patient immune genetics and type of cancer: a pilot study.

Coller JK, White IA, Logan RM, Tuke J, Richards AM, Mead KR, Karapetis CS, Bowen JM.

Support Care Cancer. 2015 May;23(5):1233-6. doi: 10.1007/s00520-014-2481-z. Epub 2014 Oct 16.

PMID:
25318697
16.

Involvement of matrix metalloproteinases (MMP-3 and MMP-9) in the pathogenesis of irinotecan-induced oral mucositis.

Al-Azri AR, Gibson RJ, Bowen JM, Stringer AM, Keefe DM, Logan RM.

J Oral Pathol Med. 2015 Jul;44(6):459-67. doi: 10.1111/jop.12255. Epub 2014 Sep 12.

PMID:
25213123
17.

Development of the rat model of lapatinib-induced diarrhoea.

Bowen JM.

Scientifica (Cairo). 2014;2014:194185. doi: 10.1155/2014/194185. Epub 2014 Jul 7. Review.

18.

Determining the mechanisms of lapatinib-induced diarrhoea using a rat model.

Bowen JM, Mayo BJ, Plews E, Bateman E, Wignall A, Stringer AM, Boyle FM, Keefe DM.

Cancer Chemother Pharmacol. 2014 Sep;74(3):617-27. doi: 10.1007/s00280-014-2519-4. Epub 2014 Jul 24.

PMID:
25055934
19.

Evaluation of a chronic disease management system for the treatment and management of diabetes in primary health care practices in Ontario: an observational study.

O'Reilly DJ, Bowen JM, Sebaldt RJ, Petrie A, Hopkins RB, Assasi N, MacDougald C, Nunes E, Goeree R.

Ont Health Technol Assess Ser. 2014 Apr 1;14(3):1-37. eCollection 2014.

20.

Lymphoma diagnosis at an academic centre: rate of revision and impact on patient care.

Bowen JM, Perry AM, Laurini JA, Smith LM, Klinetobe K, Bast M, Vose JM, Aoun P, Fu K, Greiner TC, Chan WC, Armitage JO, Weisenburger DD.

Br J Haematol. 2014 Jul;166(2):202-8. doi: 10.1111/bjh.12880. Epub 2014 Apr 4.

PMID:
24697285
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk